OpenScience.ink

1 week ago • Shoulder & elbow

How drugs that activate GLP-1 receptors may affect recovery after rotator cuff surgeryThe impact of glucagon-like peptide-1 (GLP-1) receptor agonists on postoperative outcomes following rotator cuff repair.

📖 Top 30% JournalArticle

1 week ago • Diabetes, obesity & metabolism

Links Between GLP-1 Receptor Drugs and Heart, Kidney, and Liver Health Compared to Other Diabetes Medicines in Type 2 DiabetesAssociation of GLP-1 Receptor Agonists Versus Other Antidiabetic Medications With Cardiovascular, Renal, and Liver Outcomes in Patients With Type 2 Diabetes.

Article

1 week ago • Diabetes, obesity & metabolism

Safety and How the Body Processes the UBT251 Injection Acting on Metabolism-Related Receptors: A Early-Stage Controlled StudySafety, Pharmacokinetics and Pharmacodynamics of the GLP-1/GIP/GCG Receptor Agonist UBT251 Injection: A Randomized, Placebo-Controlled Phase 1a/1b Study.

Article

1 week ago • Current medical research and opinion

Gallbladder disease risk with GLP-1 receptor agonists versus DPP-4 inhibitors in type 2 diabetesA retrospective cohort study on the comparative safety of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on the onset of gallbladder disease in type II diabetes.

Article

1 week ago • American journal of nephrology

Orforglipron and Kidney Health: Potential Benefits or Risks? The Need for Studies on Kidney OutcomesOrforglipron and the Kidney: A Promise or Disappointment? The Need for Trials Examining Renal Outcomes.

🎖️ Top 10% JournalArticle

1 week ago • Endocrinology, diabetes & metabolism

Effectiveness and Safety of Tirzepatide Compared to Dulaglutide in Type 2 Diabetes With or Without Heart and Blood Vessel DiseaseEfficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials.

📖 Top 20% JournalNetwork Meta-Analysis

1 week ago • Frontiers in pharmacology

How Gut Bacteria, Medicines, and the Body Interact in Metabolic Syndrome and Type 2 DiabetesPharmacomicrobiomics in metabolic syndrome and type 2 diabetes: the microbiome-drug-host triad.

📖 Top 20% JournalArticle

1 week ago • Diabetes therapy : research, treatment and education of diabetes and related disorders

Tirzepatide’s early effects on blood sugar and weight in people with type 2 diabetes in Japan: Study plan and starting dataTirzepatide Benefit for Early Glycemic and Weight Management in People with T2D in Japan: Rationale, Design, and Baseline Characteristics of T-BEAT Study.

📖 Top 20% JournalArticle

1 week ago • Cardiovascular & hematological disorders drug targets

Using SGLT-2 Inhibitors and GLP-1 Receptor Agonists to Manage Metabolic Syndrome in Type 2 DiabetesSGLT-2 Inhibitors and GLP-1 Receptor Agonists in Managing Metabolic Syndrome Among Patients with Type 2 Diabetes Mellitus - A Narrative Review.

Article

1 week ago • Journal of medical Internet research

Using Digital Support to Improve GLP-1 Drug Treatment: Focus on Staying on Treatment, Side Effects, and Lasting Benefits After StoppingDigital Behavioral Infrastructure for Glucagon-Like Peptide-1 Pharmacotherapy: Viewpoint on Persistence, Tolerability, and Postcessation Durability.

🥉 Top 5% JournalArticle

1 week ago • Clinics in dermatology

Ethical issues of prescribing cosmetic GLP-1 drugs in skin careEthical Considerations of Cosmetic GLP-1 Receptor Agonist Prescribing in Dermatology.

📖 Top 50% JournalArticle

1 week ago • Obesity science & practice

Malnutrition and Metabolic Problems Linked to High-Potency Incretin Treatments: A Review and AnalysisA Systematic Review and Meta-Analysis of Malnutrition and Metabolic Failure in High-Potency Incretin Therapy.

📖 Top 30% JournalArticle

1 week ago • Cell metabolism

Possible Effects of GLP-1 Receptor Agonists on Fertility in Women with Polycystic Ovary SyndromeImplications of GLP-1 receptor agonists for the fertility of women with polyendocrine metabolic ovarian syndrome.

🥇 Top 1% JournalArticle

1 week ago • European heart journal. Cardiovascular pharmacotherapy

Events linked to vagus nerve activity and drugs that activate GLP-1 receptorsVagal activity related events and glucagon-like peptide-1 receptor agonists.

🥉 Top 5% JournalArticle

1 week ago • Clinical therapeutics

Comparing finerenone combined with two or three diabetes medicines in chronic kidney disease linked to type 2 diabetesFinerenone-Based Dual Versus Triple Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus Associated Chronic Kidney Disease: A Retrospective Cohort Study.

Article

1 week ago • British journal of anaesthesia

Slower stomach emptying in teens taking GLP-1 medicines before surgery with standard fasting rulesDelayed gastric emptying in adolescent patients on GLP-1 receptor agonists with standard preoperative fasting guidelines: a prospective cohort study.

🥉 Top 5% JournalArticle

1 week ago • International journal of cardiology

Tirzepatide linked to heart structure improvement and better heart relaxation in obesity-related heart failure with preserved pumpingAssociation of tirzepatide with reverse cardiac remodeling and improved diastolic function in obesity-related HFpEF: A prospective real-world cohort study.

Article

1 week ago • Clinics in dermatology

Ethical Issues of Using GLP-1 Receptor Drugs in Skin TreatmentsGLP-1 Receptor Agonists in Dermatology: Ethical Considerations.

📖 Top 50% JournalArticle

1 week ago • Pharmaceutical development and technology

Creating Stable Microspheres to Deliver Exenatide Using Polarity Gradient ExtractionDevelopment of Chondroitin Sulfate ‑ Stabilized PLGA Microspheres of Exenatide via Polarity Gradient Extraction.

📖 Top 50% JournalArticle

1 week ago • Frontiers in endocrinology

Social and mental health challenges in children with fatty liver diseasePsychosocial aspects and mental health burden of pediatric MASLD.

🎖️ Top 10% JournalArticle

1 week ago • Cureus

Tirzepatide treatment linked to broad metabolic improvements in an active duty service memberTirzepatide-Based Therapy for Multidomain Metabolic Improvement in an Active Duty Service Member: A Case Report.

Case Reports

1 week ago • Zhonghua yi xue za zhi

Glucagon-like peptide-1 receptor agonists: from controlling metabolism to treating rheumatic diseases[Glucagon-like peptide-1 receptor agonists: from metabolic regulation to rheumatic disease therapy].

English Abstract

1 week ago • Journal of neurology

Nerve problems in type 2 diabetes linked to GLP-1 receptor drugs compared to DPP-4 inhibitor drugsGLP-1 receptor agonists vs DPP-4 inhibitors and neuropathic complications in type 2 diabetes.

🎖️ Top 10% JournalComparative Study

1 week ago • Critical reviews in food science and nutrition

How Diet and the Hormone GLP-1 Work Together in Metabolism and AgingInteractions between dietary intake and GLP-1 biology: implications for metabolic dysfunction and aging.

🥉 Top 5% JournalArticle

1 week ago • The spine journal : official journal of the North American Spine Society

How Different GLP-1 Doses Affect Short- and Long-Term Recovery After Neck Spine Fusion SurgeryImpact of GLP-1 Dose Intensity on Perioperative and Long-Term Fusion Outcomes Following ACDF.

🥉 Top 5% JournalArticle

1 week ago • Cardiovascular diabetology. Endocrinology reports

GLP-1 receptor agonists may protect the heart, kidneys, and metabolism beyond blood sugar controlGLP-1 receptor agonists beyond glycemic control: integrated cardio-renal-metabolic protection across the cardiovascular kidney metabolic continuum.

Article

1 week ago • Immunopharmacology and immunotoxicology

Improvement of post-COVID-19 vaccination nerve system imbalance with GLP-1 receptor activatorImprovement of post-COVID-19 vaccination dysautonomia with GLP-1 receptor agonist.

📖 Top 30% JournalArticle

1 week ago • JGH open : an open access journal of gastroenterology and hepatology

How Medicines for Treating Obesity Have Changed Over TimeThe Evolution of Medications for Obesity Management.

📖 Top 50% JournalArticle

1 week ago • Journal of orthopaedic surgery (Hong Kong)

Use of Glucagon-like Peptide-1 Receptor Agonists Linked to Lower Risk of Joint Infection After Total Knee Replacement, Confirmed by Side-by-Side ComparisonGlucagon-like Peptide-1 receptor agonist use is associated with decreased risk of periprosthetic joint infection following total knee arthroplasty: A laterality-verified propensity matched comparison.

📖 Top 50% JournalComparative Study

1 week ago • High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

Loss of Muscle During Weight Loss with Glucagon-like Peptide-1 Treatments: Rethinking Its ImportanceLean Mass Reduction During Glucagon-like Peptide-1 Receptor Agonists-Induced Weight Loss: Rethinking Its Clinical Significance.

📖 Top 20% JournalArticle

← prevpage 6 of 14next →

Latest GLP-1 Therapies Research Papers